Dexcom

CompanyUnited StatesFounded 1999

Wikidata

Dexcom develops 2 assets, the furthest in human trials (Stelo glucose biosensor in polycystic ovarian syndrome). Mostly device; based in the United States, founded in 1999.

2
Assets
Furthest stage
Human trials
0
Trials
2
Signals

Pipeline

2
  • Stelo glucose biosensor

    Continuous glucose biosensor measuring interstitial glucose levels

    Human trials, Device, polycystic ovarian syndrome

  • Stelo

    Continuously measures interstitial glucose to provide glucose profiles and metabolic health insights.

    Stage not known, Device

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials2
  • People1
  • Signals20

Papers

Intelligence